These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 11179329
1. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Cooper PJ, Chico M, Sandoval C, Espinel I, Guevara A, Levine MM, Griffin GE, Nutman TB. Infect Immun; 2001 Mar; 69(3):1574-80. PubMed ID: 11179329 [Abstract] [Full Text] [Related]
2. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. Cooper PJ, Chico ME, Losonsky G, Sandoval C, Espinel I, Sridhara R, Aguilar M, Guevara A, Guderian RH, Levine MM, Griffin GE, Nutman TB. J Infect Dis; 2000 Oct; 182(4):1199-206. PubMed ID: 10979918 [Abstract] [Full Text] [Related]
3. Repeated treatments with albendazole enhance Th2 responses to Ascaris Lumbricoides, but not to aeroallergens, in children from rural communities in the Tropics. Cooper PJ, Moncayo AL, Guadalupe I, Benitez S, Vaca M, Chico M, Griffin GE. J Infect Dis; 2008 Oct 15; 198(8):1237-42. PubMed ID: 18729781 [Abstract] [Full Text] [Related]
4. Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. Cooper PJ, Chico ME, Sandoval C, Espinel I, Guevara A, Kennedy MW, Urban JF, Griffin GE, Nutman TB. J Infect Dis; 2000 Oct 15; 182(4):1207-13. PubMed ID: 10979919 [Abstract] [Full Text] [Related]
5. Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection. Blish CA, Sangaré L, Herrin BR, Richardson BA, John-Stewart G, Walson JL. J Infect Dis; 2010 Jun 15; 201(12):1816-21. PubMed ID: 20441516 [Abstract] [Full Text] [Related]
6. Cellular responses and cytokine profiles in Ascaris lumbricoides and Trichuris trichiura infected patients. Geiger SM, Massara CL, Bethony J, Soboslay PT, Carvalho OS, Corrêa-Oliveira R. Parasite Immunol; 2002 Jun 15; 24(11-12):499-509. PubMed ID: 12694600 [Abstract] [Full Text] [Related]
7. Ascaris lumbricoides infection in urban schoolchildren: specific IgE and IL-10 production. Souza V, Medeiros D, Sales I, Costa V, Silva A, Rizzo J, Sole D, Sarinho E. Allergol Immunopathol (Madr); 2014 Jun 15; 42(3):206-11. PubMed ID: 23648101 [Abstract] [Full Text] [Related]
8. Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial. McCarty JM, Lock MD, Bennett S, Hunt KM, Simon JK, Gurwith M. Vaccine; 2019 Mar 07; 37(11):1389-1397. PubMed ID: 30772070 [Abstract] [Full Text] [Related]
9. Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator. Sow SO, Tapia MD, Chen WH, Haidara FC, Kotloff KL, Pasetti MF, Blackwelder WC, Traoré A, Tamboura B, Doumbia M, Diallo F, Coulibaly F, Onwuchekwa U, Kodio M, Tennant SM, Reymann M, Lam DF, Gurwith M, Lock M, Yonker T, Smith J, Simon JK, Levine MM. Clin Vaccine Immunol; 2017 Dec 07; 24(12):. PubMed ID: 29021299 [Abstract] [Full Text] [Related]
10. Comparison of Cytokine Responses in Ecuadorian Children Infected with Giardia, Ascaris, or Both Parasites. Weatherhead J, Cortés AA, Sandoval C, Vaca M, Chico M, Loor S, Cooper PJ, Mejia R. Am J Trop Med Hyg; 2017 Jun 07; 96(6):1394-1399. PubMed ID: 28719267 [Abstract] [Full Text] [Related]
11. [Cytokine measurement using a multiplex technique with spectral flow cytometry: application in the study of the immunobiology of ascariasis]. Lozano A, Sánchez-Marrugo C, Llinás-Caballero K, Barrios C, Acevedo N, Zakzuk J, Caraballo L. Rev Alerg Mex; 2024 Feb 01; 71(1):64-65. PubMed ID: 38683082 [Abstract] [Full Text] [Related]
12. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Tacket CO, Cohen MB, Wasserman SS, Losonsky G, Livio S, Kotloff K, Edelman R, Kaper JB, Cryz SJ, Giannella RA, Schiff G, Levine MM. Infect Immun; 1999 Dec 01; 67(12):6341-5. PubMed ID: 10569747 [Abstract] [Full Text] [Related]
13. Chronic intestinal helminth infections are associated with immune hyporesponsiveness and induction of a regulatory network. Figueiredo CA, Barreto ML, Rodrigues LC, Cooper PJ, Silva NB, Amorim LD, Alcantara-Neves NM. Infect Immun; 2010 Jul 01; 78(7):3160-7. PubMed ID: 20404082 [Abstract] [Full Text] [Related]
14. Evidence for in utero sensitization to Ascaris lumbricoides in newborns of mothers with ascariasis. Guadalupe I, Mitre E, Benitez S, Chico ME, Nutman TB, Cooper PJ. J Infect Dis; 2009 Jun 15; 199(12):1846-50. PubMed ID: 19426111 [Abstract] [Full Text] [Related]
15. A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children. Brückner S, Agnandji ST, Elias J, Berberich S, Bache E, Fernandes J, Loembe MM, Hass J, Lell B, Mordmüller B, Adegnika AA, Kremsner P, Esen M. Vaccine; 2016 Oct 17; 34(44):5384-5390. PubMed ID: 27642131 [Abstract] [Full Text] [Related]
16. Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults. Migasena S, Pitisuttitham P, Prayurahong B, Suntharasamai P, Supanaranond W, Desakorn V, Vongsthongsri U, Tall B, Ketley J, Losonsky G. Infect Immun; 1989 Nov 17; 57(11):3261-4. PubMed ID: 2807523 [Abstract] [Full Text] [Related]
19. Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection. Haney DJ, Lock MD, Gurwith M, Simon JK, Ishioka G, Cohen MB, Kirkpatrick BD, Lyon CE, Chen WH, Sztein MB, Levine MM, Harris JB. Vaccine; 2018 May 11; 36(20):2768-2773. PubMed ID: 29655627 [Abstract] [Full Text] [Related]
20. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. Islam K, Hossain M, Kelly M, Mayo Smith LM, Charles RC, Bhuiyan TR, Kováč P, Xu P, LaRocque RC, Calderwood SB, Simon JK, Chen WH, Haney D, Lock M, Lyon CE, Kirkpatrick BD, Cohen M, Levine MM, Gurwith M, Harris JB, Qadri F, Ryan ET. PLoS Negl Trop Dis; 2018 Apr 11; 12(4):e0006376. PubMed ID: 29624592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]